Optomed: Comment on the decreased full-year outlook - Redeye
Redeye provides a short comment on Optomed’s decreased full-year outlook. We learn that the uncertainty in the Chinese market continues but note the other global sales channels have performed well.
ANNONS
Redeye provides a short comment on Optomed’s decreased full-year outlook. We learn that the uncertainty in the Chinese market continues but note the other global sales channels have performed well.